In vivo effects of imatinib mesylate on human haematopoietic progenitor cells. [electronic resource]
Producer: 20060915Description: 402-8 p. digitalISSN:- 0014-2972
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Benzamides
- Brain Neoplasms -- blood
- Female
- Follow-Up Studies
- Hematopoiesis -- drug effects
- Hematopoietic Stem Cells -- drug effects
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- blood
- Male
- Middle Aged
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.